658
Participants
Start Date
May 28, 2019
Primary Completion Date
January 31, 2022
Study Completion Date
January 31, 2022
Non-interventional
No intervention will be administered.
Site #32, Cheonan
Site #35, Bucheon-si
Site #38, Bucheon-si
Site #06, Goyang-si
Site #03, Seongnam-si
Site #13, Suwon
Site #27, Suwon
Site #15, Uijeongbu-si
Site #37, Changwon
Site #28, Yangsan
Site #29, Yangsan
Site #31, Busan
Site #39, Busan
Site #40, Busan
Site #17, Daegu
Site #18, Daegu
Site #26, Daegu
Site #30, Daegu
Site #41, Daegu
Site #19, Daejeon
Site #20, Daejeon
Site #24, Daejeon
Site #34, Daejeon
Site #21, Incheon
Site #33, Incheon
Site #36, Incheon
Site #01, Seoul
Site #02, Seoul
Site #04, Seoul
Site #07, Seoul
Site #08, Seoul
Site #09, Seoul
Site #10, Seoul
Site #12, Seoul
Site #16, Seoul
Site #22, Seoul
Site #23, Seoul
Site #25, Seoul
Site #42, Seoul
Site #43, Seoul
Site #44, Seoul
Site #11, Ulsan
Eisai Korea Inc.
INDUSTRY